Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

TAK Takeda Pharmaceutical

12.995
-0.075-0.57%
Trading Session 09/29 10:09 ET
High
13.070
Open
13.070
Turnover
7.87M
Low
12.954
Pre Close
13.070
Volume
604.56K
Market Cap
40.18B
P/E(TTM)
28.01
52wk High
16.390
Shares
3.09B
P/E(Static)
21.69
52wk Low
12.750
Float Cap
39.55B
Bid/Ask %
-26.61%
Historical High
21.610
Shs Float
3.04B
Volume Ratio
1.85
Historical Low
12.430
Dividend TTM
0.624
Div Yield TTM
0.696
P/B
0.92
Dividend LFY
4.80%
Div Yield LFY
5.36%
Turnover Ratio
0.02%
Amplitude
0.89%
Avg Price
13.025
Lot Size
1
Float Cap
39.55B
Bid/Ask %
-26.61%
Historical High
21.610
Shs Float
3.04B
Volume Ratio
1.85
Historical Low
12.430
Dividend TTM
0.624
P/B
0.92
Dividend LFY
4.80%
Turnover Ratio
0.02%
Amplitude
0.89%
Avg Price
13.025
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
CEO: Mr. Christophe Weber
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...